Myostatin as a Biomarker for Diagnosis or Prognosis of Frailty and Sarcopenia: Current Knowledge

Gerontology. 2019;65(4):385-386. doi: 10.1159/000496469. Epub 2019 Mar 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Biomarkers
  • Exercise Therapy
  • Frailty*
  • Humans
  • Myostatin
  • Nursing Homes
  • Prognosis
  • Sarcopenia*

Substances

  • Biomarkers
  • Myostatin